(Q36681776)

15 August 2017

1 reference

title

Sitaxsentan for treatment of pulmonary hypertension (English)

1 reference

15 August 2017

Eric T Wittbrodt

1

1 reference

15 August 2017

Amina Abubakar

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

12 December 2006

1 reference

Annals of Pharmacotherapy

15 August 2017

published in

1 reference

15 August 2017

volume

41

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

100-105

1 reference

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

15 August 2017

cites work

1 reference

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

Endothelin receptor antagonists in pulmonary arterial hypertension.

21 January 2018

1 reference

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist

21 January 2018

1 reference

Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.

21 January 2018

1 reference

Sitaxsentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.

21 January 2018

1 reference

STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials.

21 January 2018

1 reference

Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study

21 January 2018

1 reference

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G254

1 reference

15 August 2017

1 reference